39 related articles for article (PubMed ID: 2856203)
1. MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment.
Griffith BD; Turcotte S; Lazarus J; Lima F; Bell S; Delrosario L; McGue J; Krishnan S; Oneka MD; Nathan H; Smith JJ; D'Angelica MI; Shia J; Di Magliano MP; Rao A; Frankel TL
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077630
[TBL] [Abstract][Full Text] [Related]
2. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for
Jou E; Rodriguez-Rodriguez N; Ferreira AF; Jolin HE; Clark PA; Sawmynaden K; Ko M; Murphy JE; Mannion J; Ward C; Matthews DJ; Buczacki SJA; McKenzie ANJ
Sci Immunol; 2022 Jun; 7(72):eabn0175. PubMed ID: 35658010
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.
Chen P; Zhao L; Wang H; Zhang L; Zhang W; Zhu J; Yu J; Zhao S; Li W; Sun C; Wu C; He Y; Zhou C
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34362829
[TBL] [Abstract][Full Text] [Related]
4. HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.
Anderson P; Aptsiauri N; Ruiz-Cabello F; Garrido F
Cell Mol Immunol; 2021 Mar; 18(3):556-565. PubMed ID: 33473191
[TBL] [Abstract][Full Text] [Related]
5. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
[TBL] [Abstract][Full Text] [Related]
6. HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.
Seliger B; Kloor M; Ferrone S
Oncoimmunology; 2017; 6(2):e1171447. PubMed ID: 28344859
[TBL] [Abstract][Full Text] [Related]
7. Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.
Surmann EM; Voigt AY; Michel S; Bauer K; Reuschenbach M; Ferrone S; von Knebel Doeberitz M; Kloor M
Cancer Immunol Immunother; 2015 Mar; 64(3):357-66. PubMed ID: 25445815
[TBL] [Abstract][Full Text] [Related]
8. HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Sconocchia G; Eppenberger-Castori S; Zlobec I; Karamitopoulou E; Arriga R; Coppola A; Caratelli S; Spagnoli GC; Lauro D; Lugli A; Han J; Iezzi G; Ferrone C; Ferlosio A; Tornillo L; Droeser R; Rossi P; Attanasio A; Ferrone S; Terracciano L
Neoplasia; 2014 Jan; 16(1):31-42. PubMed ID: 24563618
[TBL] [Abstract][Full Text] [Related]
9. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis.
Løvig T; Andersen SN; Thorstensen L; Diep CB; Meling GI; Lothe RA; Rognum TO
Br J Cancer; 2002 Sep; 87(7):756-62. PubMed ID: 12232760
[TBL] [Abstract][Full Text] [Related]
10. The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.
Svane IM; Boesen M; Engel AM
Med Oncol; 1999 Dec; 16(4):223-38. PubMed ID: 10618685
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutations and HLA-DR expression in large bowel adenomas.
Norheim Andersen S; Breivik J; Løvig T; Meling GI; Gaudernack G; Clausen OP; Schjölberg A; Fausa O; Langmark F; Lund E; Rognum TO
Br J Cancer; 1996 Jul; 74(1):99-108. PubMed ID: 8679466
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.
Ogoshi K; Tajima T; Mitomi T; Tsuji K
Clin Exp Metastasis; 1996 May; 14(3):277-81. PubMed ID: 8674282
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
14. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.
Andersen SN; Rognum TO; Lund E; Meling GI; Hauge S
Br J Cancer; 1993 Jul; 68(1):80-5. PubMed ID: 8318425
[TBL] [Abstract][Full Text] [Related]
15. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
Esteban F; Ruiz-Cabello F; Concha A; Pérez-Ayala M; Sánchez-Rozas JA; Garrido F
Clin Exp Metastasis; 1990; 8(4):319-28. PubMed ID: 2350918
[TBL] [Abstract][Full Text] [Related]
18. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Gutierrez J; López-Nevot MA; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
Exp Clin Immunogenet; 1987; 4(3):144-52. PubMed ID: 2856203
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.
Tamiolakis D; Venizelos J; Papadopoulos N; Lambropoulou M; Papadopoulos E; Simopoulos C
Chirurgia (Bucur); 2005; 100(5):451-6. PubMed ID: 16372671
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
